Health Care & Life Sciences » Pharmaceuticals | Mercury Laboratories Ltd.

Mercury Laboratories Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2015
2016
2017
2018
Net Income before Extraordinaries
46,049.80
49,357.30
48,942.90
-
Depreciation, Depletion & Amortization
11,805.60
11,840.30
12,885.30
-
Other Funds
-
-
30.50
-
Funds from Operations
45,101.70
47,111.10
50,666.40
34,878.00
Changes in Working Capital
10,243.90
48,081.30
40,363.50
-
Net Operating Cash Flow
34,857.90
970.10
10,302.80
-
Capital Expenditures
15,428.70
2,790.20
15,009.30
-
Net Investing Cash Flow
15,428.70
2,790.20
15,009.30
-
Cash Dividends Paid - Total
2,092.00
2,166.40
2,166.40
-
Issuance/Reduction of Debt, Net
19,156.00
6,876.10
8,515.60
-
Net Financing Cash Flow
21,248.10
4,709.60
6,379.70
-
Net Change in Cash
1,818.90
949.30
1,673.20
-
Free Cash Flow
19,429.10
3,760.30
4,706.50
-

About Mercury Laboratories

View Profile
Address
2/13 & 14, Gorwa Industrial Estate
Vadodara Gujarat 390016
India
Employees -
Website http://www.mercurylabs.com
Updated 09/14/2018
Mercury Laboratories Ltd. engages in the pharmaceutical business, which manufactures, exports, imports, and deals pharmaceutical products for mother and child healthcare. It offers products for pediatrics, obstetrics, gynecology, and surgery segments. The company was founded 1962 and is headquartered in Vadodara, India.